Dolastatin 10

未知生产厂商

Dolastatin 10 has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Liver Cancer, and Kidney Cancer, among others.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Dolastatin 10 has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Liver Cancer, and Kidney Cancer, among others.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Antibody-drug-conjugate and its use for the treatment of cancer
US 10314921 B2申请人: PF MEDICAMENT优先权: 2014
US
5 件公开
Dolastatin 10 derivatives
US 2003055002 A1申请人: FUJII TOSHIHIKO优先权: 2001
CN
US
3 件公开
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer
US 10633448 B2申请人: PF MEDICAMENT优先权: 2014
EP
US
3 件公开
3-Pyrrolidin-2-yl-propionic acid derivatives
US 2006128970 A1申请人: BLISS FRITZ优先权: 2004
CN
US
2 件公开
Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
US 9278996 B2申请人: CELLTRION INC优先权: 2012
CN
US
2 件公开
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER
- EP 4400121 A1
  申请人: TORAY INDUSTRIES优先权: 2021
  EP
  US
  2 件公开
- WO 2026034524 A1
  申请人: TORAY INDUSTRIES优先权: 2024
  WO
FAP TARGETED ANTIBODY-DRUG CONJUGATES
EP 4616869 A1申请人: ONCOMATRYX BIOPHARMA S L优先权: 2024
EP
WO
2 件公开
Derivatives of dolastatin 10 and auristatins
CN 105143199 A申请人: PF MEDICAMENT优先权: 2014
CN
2 件公开
Novel pharmaceutical composition containing at least one dolastatin 10 derivative
CN 101076371 A申请人: HOFFMANN LA ROCHE优先权: 2004
CN
Method for the treatment of cancer using a novel pharmaceutical composition containing at least one dolastatin 10 derivative
US 2006292158 A1申请人: AOKI YUKO优先权: 2004
US